US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist
  • 45.210
  • -1.180-2.54%
Close Nov 29 13:00 ET
  • 45.210
  • 0.0000.00%
Post 17:01 ET
2.37BMarket Cap-38641P/E (TTM)

Janux Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
80.95%-2.23M
33.43%-10.02M
-6.66%-14.84M
-17.83%-50.58M
16.89%-9.9M
12.71%-11.71M
-147.88%-15.05M
-20.73%-13.91M
-152.84%-42.92M
-13.66%-11.91M
Net income from continuing operations
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
Depreciation and amortization
2.00%510K
7.43%506K
17.44%532K
132.46%1.96M
31.76%531K
100.80%500K
336.11%471K
459.26%453K
644.25%841K
529.69%403K
Change In working capital
516.39%12.83M
-338.40%-7.35M
-535.29%-4.45M
-253.27%-6.55M
-231.10%-1.1M
-287.55%-3.08M
-126.36%-1.68M
67.09%-700K
-51.64%4.28M
5,673.33%836K
-Change in receivables
----
-1,030.80%-6.98M
30.80%-519K
----
----
----
--750K
---750K
----
----
-Change in prepaid assets
-127.17%-144K
21.30%-1.76M
-171.01%-1.17M
106.23%210K
433.33%270K
140.74%530K
-281.43%-2.24M
217.79%1.65M
-86.65%-3.37M
-400.00%-81K
-Change in payables and accrued expense
426.78%5.75M
86.01%2.37M
-204.20%-2.03M
-110.38%-401K
-38.68%753K
-178.07%-1.76M
3,537.84%1.27M
-259.57%-667K
-25.26%3.86M
-14.66%1.23M
-Change in other current assets
-253.78%-183K
85.89%-116K
93.21%-15K
11.89%-1.12M
37.70%-195K
110.42%119K
-732.31%-822K
-501.82%-221K
-223.98%-1.27M
-24.21%-313K
-Change in other working capital
95.33%-92K
-34.64%-859K
-0.28%-713K
-203.78%-5.24M
-286.35%-1.92M
-1,777.14%-1.97M
-109.31%-638K
40.75%-711K
337.45%5.05M
59.48%-498K
Cash from discontinued investing activities
Operating cash flow
80.95%-2.23M
33.43%-10.02M
-6.66%-14.84M
-17.83%-50.58M
16.89%-9.9M
12.71%-11.71M
-147.88%-15.05M
-20.73%-13.91M
-152.84%-42.92M
-13.66%-11.91M
Investing cash flow
Cash flow from continuing investing activities
120.62%12.67M
-1,167.95%-190.89M
-1,201.33%-113.74M
-170.70%-41.19M
793.45%11.12M
-410.94%-61.45M
97.74%17.87M
-128.13%-8.74M
117.09%58.27M
-121.89%-1.6M
Net PPE purchase and sale
94.68%-25K
83.62%-95K
30.88%-197K
71.30%-1.85M
74.95%-515K
81.35%-470K
35.41%-580K
70.65%-285K
-334.89%-6.45M
-75.28%-2.06M
Net investment purchase and sale
120.82%12.7M
-1,133.87%-190.79M
-1,242.86%-113.54M
-160.80%-39.34M
2,474.78%11.64M
-373.67%-60.98M
85.71%18.45M
-126.39%-8.46M
119.06%64.71M
-94.68%452K
Cash from discontinued investing activities
Investing cash flow
120.62%12.67M
-1,167.95%-190.89M
-1,201.33%-113.74M
-170.70%-41.19M
793.45%11.12M
-410.94%-61.45M
97.74%17.87M
-128.13%-8.74M
117.09%58.27M
-121.89%-1.6M
Financing cash flow
Cash flow from continuing financing activities
-97.09%1.65M
423.67%2.77M
20,290.57%322.17M
11,809.60%59.55M
335.08%831K
56.61M
71.43%528K
157,900.00%1.58M
-99.87%500K
16.46%191K
Net common stock issuance
--0
---455K
--320.51M
--56.53M
--0
--56.53M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
1,987.34%1.65M
509.85%3.22M
4.87%1.66M
503.60%3.02M
335.08%831K
--79K
71.43%528K
157,900.00%1.58M
-72.38%500K
16.46%191K
Cash from discontinued financing activities
Financing cash flow
-97.09%1.65M
423.67%2.77M
20,290.57%322.17M
11,809.60%59.55M
335.08%831K
--56.61M
71.43%528K
157,900.00%1.58M
-99.87%500K
16.46%191K
Net cash flow
Beginning cash position
-55.16%15.48M
585.31%213.62M
-61.68%20.02M
43.53%52.24M
-72.60%17.97M
-41.71%34.52M
-44.28%31.17M
43.53%52.24M
365.86%36.4M
66.46%65.57M
Current changes in cash
173.06%12.09M
-6,018.19%-198.14M
1,018.79%193.6M
-303.36%-32.22M
115.41%2.05M
-360.69%-16.55M
2.26%3.35M
-207.80%-21.07M
-44.57%15.84M
-345.54%-13.33M
End cash Position
53.44%27.57M
-55.16%15.48M
585.31%213.62M
-61.68%20.02M
-61.68%20.02M
-72.60%17.97M
-41.71%34.52M
-44.28%31.17M
43.53%52.24M
43.53%52.24M
Free cash flow
81.48%-2.26M
35.29%-10.12M
-5.90%-15.03M
-6.19%-52.43M
25.43%-10.42M
23.57%-12.18M
-124.27%-15.63M
-13.63%-14.2M
-167.46%-49.37M
-19.86%-13.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 80.95%-2.23M33.43%-10.02M-6.66%-14.84M-17.83%-50.58M16.89%-9.9M12.71%-11.71M-147.88%-15.05M-20.73%-13.91M-152.84%-42.92M-13.66%-11.91M
Net income from continuing operations -142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M
Depreciation and amortization 2.00%510K7.43%506K17.44%532K132.46%1.96M31.76%531K100.80%500K336.11%471K459.26%453K644.25%841K529.69%403K
Change In working capital 516.39%12.83M-338.40%-7.35M-535.29%-4.45M-253.27%-6.55M-231.10%-1.1M-287.55%-3.08M-126.36%-1.68M67.09%-700K-51.64%4.28M5,673.33%836K
-Change in receivables -----1,030.80%-6.98M30.80%-519K--------------750K---750K--------
-Change in prepaid assets -127.17%-144K21.30%-1.76M-171.01%-1.17M106.23%210K433.33%270K140.74%530K-281.43%-2.24M217.79%1.65M-86.65%-3.37M-400.00%-81K
-Change in payables and accrued expense 426.78%5.75M86.01%2.37M-204.20%-2.03M-110.38%-401K-38.68%753K-178.07%-1.76M3,537.84%1.27M-259.57%-667K-25.26%3.86M-14.66%1.23M
-Change in other current assets -253.78%-183K85.89%-116K93.21%-15K11.89%-1.12M37.70%-195K110.42%119K-732.31%-822K-501.82%-221K-223.98%-1.27M-24.21%-313K
-Change in other working capital 95.33%-92K-34.64%-859K-0.28%-713K-203.78%-5.24M-286.35%-1.92M-1,777.14%-1.97M-109.31%-638K40.75%-711K337.45%5.05M59.48%-498K
Cash from discontinued investing activities
Operating cash flow 80.95%-2.23M33.43%-10.02M-6.66%-14.84M-17.83%-50.58M16.89%-9.9M12.71%-11.71M-147.88%-15.05M-20.73%-13.91M-152.84%-42.92M-13.66%-11.91M
Investing cash flow
Cash flow from continuing investing activities 120.62%12.67M-1,167.95%-190.89M-1,201.33%-113.74M-170.70%-41.19M793.45%11.12M-410.94%-61.45M97.74%17.87M-128.13%-8.74M117.09%58.27M-121.89%-1.6M
Net PPE purchase and sale 94.68%-25K83.62%-95K30.88%-197K71.30%-1.85M74.95%-515K81.35%-470K35.41%-580K70.65%-285K-334.89%-6.45M-75.28%-2.06M
Net investment purchase and sale 120.82%12.7M-1,133.87%-190.79M-1,242.86%-113.54M-160.80%-39.34M2,474.78%11.64M-373.67%-60.98M85.71%18.45M-126.39%-8.46M119.06%64.71M-94.68%452K
Cash from discontinued investing activities
Investing cash flow 120.62%12.67M-1,167.95%-190.89M-1,201.33%-113.74M-170.70%-41.19M793.45%11.12M-410.94%-61.45M97.74%17.87M-128.13%-8.74M117.09%58.27M-121.89%-1.6M
Financing cash flow
Cash flow from continuing financing activities -97.09%1.65M423.67%2.77M20,290.57%322.17M11,809.60%59.55M335.08%831K56.61M71.43%528K157,900.00%1.58M-99.87%500K16.46%191K
Net common stock issuance --0---455K--320.51M--56.53M--0--56.53M--0--0--0--0
Proceeds from stock option exercised by employees 1,987.34%1.65M509.85%3.22M4.87%1.66M503.60%3.02M335.08%831K--79K71.43%528K157,900.00%1.58M-72.38%500K16.46%191K
Cash from discontinued financing activities
Financing cash flow -97.09%1.65M423.67%2.77M20,290.57%322.17M11,809.60%59.55M335.08%831K--56.61M71.43%528K157,900.00%1.58M-99.87%500K16.46%191K
Net cash flow
Beginning cash position -55.16%15.48M585.31%213.62M-61.68%20.02M43.53%52.24M-72.60%17.97M-41.71%34.52M-44.28%31.17M43.53%52.24M365.86%36.4M66.46%65.57M
Current changes in cash 173.06%12.09M-6,018.19%-198.14M1,018.79%193.6M-303.36%-32.22M115.41%2.05M-360.69%-16.55M2.26%3.35M-207.80%-21.07M-44.57%15.84M-345.54%-13.33M
End cash Position 53.44%27.57M-55.16%15.48M585.31%213.62M-61.68%20.02M-61.68%20.02M-72.60%17.97M-41.71%34.52M-44.28%31.17M43.53%52.24M43.53%52.24M
Free cash flow 81.48%-2.26M35.29%-10.12M-5.90%-15.03M-6.19%-52.43M25.43%-10.42M23.57%-12.18M-124.27%-15.63M-13.63%-14.2M-167.46%-49.37M-19.86%-13.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data